Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NOVAVAX, INC.

(NVAX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
11.29 USD   +2.82%
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société NOVAVAX, INC.
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/18Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/09Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
AQ
01/09Novavax Names John C. Jacobs as New President & Chief Executive Officer
PR
01/09Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
2022Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and St..
PR
2022Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
AQ
2022Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2..
PR
2022Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
AQ
2022Novavax Inc : Entry into a Material Definitive Agreement, Other Events, Financial Statemen..
AQ
2022German Health Authority Expands Recommendation for Use of Novavax COVID-19 Vaccine as a..
AQ
2022Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Offi..
AQ
2022Novavax Announces Pricing of $65 Million Public Offering of Common Stock
PR
2022Novavax Announces Pricing of $65 Million Public Offering of Common Stock
AQ
2022Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
AQ
2022Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
PR
2022Nordson, AbCellera rise; Warner Bros., Novavax fall
AQ
2022Novavax Inc : Regulation FD Disclosure, Other Events (form 8-K)
AQ
2022Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
PR
2022Novavax Announces Proposed $125 Million Public Offering of Common Stock
PR
2022Novavax : Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid ..
PU
2022NOVAVAX INC Change in Directors or Principal Officers (form 8-K/A)
AQ
2022Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Ad..
PR
2022Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference
AQ
2022Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference
PR
2022World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 ..
PR
2022Novavax - Termination of COVID-19 Vaccine Purchase Agreement with Gavi
AQ
2022Novavax Inc : Termination of a Material Definitive Agreement (form 8-K)
AQ
2022Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost..
AQ
2022Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost..
PR
2022Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Boost..
AQ
2022Novavax to Participate in Jefferies London Healthcare Conference
PR
2022Novavax Nuvaxovid COVID-19 Vaccine Authorized in the United Kingdom for Use as a Booste..
AQ
2022Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for U..
PR
2022NOVAVAX INC Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2022Novavax : Q3 Earnings Snapshot
AQ
2022Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights
PR
2022Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax..
PR
2022Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Ope..
AQ
2022Novavax Inc : Change in Directors or Principal Officers, Financial Statements and Exhibits..
AQ
2022Novavax Appoints Rick Rodgers to Board of Directors
PR
2022Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Ope..
PR
2022Novavax Showcases Data from Expanding Vaccine Portfolio at IDWeek 2022
PR
2022US okays Novavax covid vaccine as booster for adults
AQ
2022US clears Novavax COVID booster dose
AQ
2022US clear Novavax COVID booster dose
AQ
2022U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as..
PR
2022Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Re..
PR
2022Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting an..
PR
2022Novavax and SK bioscience file a Post Approval Change Application in South Korea for Nu..
AQ
2022Switzerland's Federal Office of Public Health Recommends Novavax Nuvaxovid COVID-19 Vac..
AQ
2022Novavax - Stanley Erck Opening Statement European Parliament - COVI Committee Hearing D..
AQ
2022Novavax : and SK bioscience File a Post Approval Change Application in South Korea for Nuv..
PU
2022Novavax : Switzerland's Federal Office of Public Health Recommends Novavax Nuvaxovid&trade..
PU
2022Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Euro..
PR
2022Novavax Inc : Entry into a Material Definitive Agreement (form 8-K)
AQ
2022Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
AQ
2022Novavax Makes One Million Doses of Nuvaxovid Available for Use in the United Kingdom
AQ
2022Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kin..
PR
2022Novavax : Requests Updated Emergency Use Listing from World Health Organization for Nuvaxo..
PU
2022Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization..
PR
2022Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged ..
PR
2022Fda Roundup : September 13, 2022
AQ
2022Novavax and Serum Institute of India Announce Full Product Registration in South Africa..
PR
2022Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Author..
PR
2022Novavax to Participate in Upcoming September Conferences
PR
2022World Health Organization Approves SK bioscience as a Supplier of Novavax Nuvaxovid COV..
AQ
2022Swissmedic Authorizes Novavax Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 Throug..
AQ
2022Swissmedic Authorizes Novavax Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12..
PR
2022Novavax Nuvaxovid™ COVID-19 Vaccine Recommended by CHMP for Expanded Conditional ..
PR
2022Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization..
AQ
2022Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Author..
PR
2022Novavax : U.S. Centers for Disease Control and Prevention Expands Recommendation for Novav..
PU
2022U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted fo..
PR
1  2  3  4  5  6  7  8  9Next
Upcoming event on NOVAVAX, INC.